Albumin Nanoparticles

A phase I/II study of albumin-bound rapamycin nanoparticles in the treatment of bacillus calmette-guerin refractory non-muscle invasive transitional cell bladder cancer.

Frailty as a predictor of complications in older patients undergoing radical cystectomy.

Some results have been hidden because they may be inaccessible to you